EP2269603

NOVARTIS
Application Number
EP10174983A
Filing Date
Feb 18, 2002
Status
Revoked
Nov 15, 2019
Grant Date
May 20, 2015
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2269603B1 was granted to Novartis on May 20, 2015 following the initial filing on Feb 18, 2002 under the application number EP10174983A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZENTIVA FRANCEJul 8, 2019INTERVENTION ADMISSIBLE
ACTAVIS PTC EHFFeb 22, 2016ADMISSIBLE
INTAS PHARMACEUTICALSFeb 22, 2016ADMISSIBLE
STADA ARZNEIMITTELFeb 22, 2016ADMISSIBLE
SYNTHONFeb 22, 2016ADMISSIBLE
WITTKOPPFeb 22, 2016ADMISSIBLE
ETHYPHARMFeb 19, 2016ADMISSIBLE
GENERICS UKFeb 19, 2016ADMISSIBLE
TEVA PHARMACEUTICALSFeb 18, 2016ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents